CIK 0001347178 · Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 030491827
- Phone
- 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- 8-K Event Results of operations
- 10-K/A Report 10-K/A
- UPLOAD Other SEC-generated Letter
- PREC14A Other PREC14A
- 10-K Report Annual Report
- SC 13G Stake Amended Statement of Ownership
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
Page 52 of 67 · 1,337 filings